Chemodex

Phenylmethylsulfonyl fluoride

As low as CHF 26.00
In stock
Only %1 left
CDX-P0492-G0011 gCHF 26.00
CDX-P0492-G0055 gCHF 39.00
CDX-P0492-G02525 gCHF 116.00
NEW
 
More Information
Product Details
Synonyms α-Toluenesulfonyl fluoride; Benzylsulfonyl fluoride; PMSF; Phenylmethanesulfonyl fluoride; NSC 88499
Product Type Chemical
Properties
Formula C7H7FO2S
MW 174.19
CAS 329-98-6
Source/Host Chemicals Synthetic
Purity Chemicals ≥99% (GC)
Appearance White to faint yellow powder or crystals.
Solubility Soluble in DMF (20 mg/ml), DMSO (20 mg/ml) or ethanol (20 mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key YBYRMVIVWMBXKQ-UHFFFAOYSA-N
Smiles O=S(CC1=CC=CC=C1)(F)=O
Shipping and Handling
Shipping AMBIENT
Short Term Storage +20°C
Long Term Storage +20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at RT.
Documents
Product Specification Sheet
Datasheet Download PDF
Description
Phenylmethylsulfonyl fluoride (PMSF) is a potent nonspecific, irreversible inhibitor of serine proteases and other enzymes, including acetylcholinesterase, palmityl coenzyme A deacylase, arylsulfatase A, chymotrypsin, and trypsin widely used in biochemical and molecular biology workflows to protect proteins from proteolytic degradation. It is used in protein solublization studies in order to deactivate proteases from digesting proteins of interest after cell lysis. Because PMSF specifically sulfonylates the hydroxal groups of active site serine residues of enzymes, it can be used as a chemical label to identify essential active site serines in an enzyme. PMSF is known to alter the actions of anandamide by blocking its metabolism and can produce cannabinoid effects in mice, including antinociception, hypothermia, and immobility with ED50 values of 86, 224, and 206 mg/kg, respectively. It is also used as a potentiator of neuropathy.
Product References
(1) P. Turini, et al.; J. Pharmacol. Exp. Ther. 167, 98 (1969) | (2) V. Sekar & J.H. Hageman; BBRC 89, 474 (1979) | (3) D.R. Compton & B.R. Martin; J. Pharmacol. Exp. Ther. 283, 1138 (1997) | (4) K.A. Skau & M.T. Shipley; Neuropharmacol. 38, 691 (1999) | (5) D. Kraut, et al.; Mol. Pharmacol. 57, 1243 (2000) | (6) Q.S. Wang, et al.; Acta Pharmacol. Sin. 22, 249 (2001) | (7) F. Song, et al.; Toxicology 262, 258 (2009) | (8) I. Mangas, et al.; Chem. Res. Toxicol. 25, 2393 (2012)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.